GLP vs. Non-GLP toxicology studies: When to use which guidelines?
Since 1978, when the U.S. FDA issued the Guidance for Industry Good Laboratory Practices Regulations, Good Laboratory Practices (GLP) have been an essential...
« Return
What It Takes to Optimize Analytical Strategies for ADC Development
Related Posts
Strategic Insights for Advancing PROTACs Toward IND Submission
Peptides present unique safety challenges, with distinct immunogenic potential and tissue distribution patterns that standard testing approaches often miss. What safety assessments cover these gaps?
Complete safety data packages enable confident IND submissions and help researchers avoid safety failures in later development stages